A few days ago, Alibaba Group stopped the opposition of major pharmacies through online tracking and sales of drugs. It can be said that Ali’s intention to use the e-commerce model to monopolize the market share of China’s pharmaceutical sales has encountered unprecedented setbacks. The resistance behind this is because of the movement of cakes from pharmaceutical factories to chain drugs.

In recent years, the Food and Drug Administration has always wanted to manage the entire industry through electronic supervision. Through electronic supervision code, it can not only check the authenticity of drugs online to combat counterfeit drugs from the source, but also promote the online sales of prescription drugs. It is convenient for consumers to compare information such as drug prices.

Ali Health saw this opportunity and proposed to cooperate with ZF to obtain the right to retail online prescription drugs, and to give an “electronic supervision code” on the minimum packaging of the drug, which is equivalent to giving the drug a qualified and unique “identity card”.

After the implementation of electronic supervision, enterprises upload information through the electronic supervision system, so that the assigned drugs can be monitored in real time no matter where they go, and consumers can also check and confirm the authenticity of the drugs through the supervision code. From the perspective of the role of supervision, the effect is perfect.

Why did you fail to get to the beach?

In fact, this practice will greatly enrich the Ali Group's data repository. Generally speaking, the variety, quantity and amount of sales in a pharmacy are as large as one year, the difference in sales in a variety of regions, the operating efficiency of a pharmaceutical company, the consumption of drugs in the disease category, and the overall health of the nationals, etc. , can be concluded through data analysis obtained by electronic supervision code. Whoever has mastered the data, whoever uses the information, the value is even more unnecessary.

Of course, chain pharmacies and pharmaceutical companies are reluctant to give up lucrative sales. A chain pharmacy called Yangtianhe Group sued the SFDA, saying it was forced to pay, and Ali health gained an unfair competitive advantage. The SFDA announced the suspension of the electronic supervision code. However, the incident did not stop there. On February 24, 19 chain pharmacies issued a statement requesting the full cancellation of the electronic supervision code. Ali Health should be fully discharged. It can be seen that "stopping" rather than "pausing" is the result that the drug dealer wants.

Ali health frustrated share price fell

Ali Health was established in 2014. Its predecessor was the data company CITIC 21st Century. In 2005, CITIC established a drug electronic supervision system in cooperation with the Food and Drug Administration. In 2014, Ali Group and Ma Yun’s private equity fund Yunfeng Fund jointly acquired a 54% stake in CITIC’s 21st century. CITIC’s 21st century was renamed Ali Health after being included by Ma Yun. Ali's online sales of over-the-counter drugs was handed over to Ali Health, and Ali was healthy and ambitious to join the regulation of the Chinese pharmaceutical market.

Ali Health has not only failed to bring more sales to the Ali Group, but because of the suspension of the drug electronic regulatory system, it lost its only source of income. According to its published earnings report, the electronic drug regulatory system generated revenue of HK$37 million for the financial year ended March 31, 2015. With the suspension of the electronic supervision code, Ali Health's share price has plummeted. The current share price is 4.11 Hong Kong dollars per share, and the highest price in 52 weeks is 14.32 Hong Kong dollars.

Extraction Kit Magnetics Bead Method

This standard specifies the terms and definitions, classification, technical requirements, test methods, identification, labels and instructions for use, packaging, transportation and storage of nucleic acid extraction kits (magnetic beads method) (hereinafter referred to as "kits"). This standard It is suitable for extracting and purifying human genomic nucleic acid and its fragments from various clinical samples such as serum, plasma, whole blood, cerebrospinal fluid, milk, saliva, urine, sputum, swab, tissue or paraffin-embedded tissue by magnetic bead method , Pathogen nucleic acid kit. Pathogen nucleic acid includes deoxyribonucleic acid (DNA), ribonucleic acid (RNA), etc. This standard does not apply to nucleic acid extraction reagents contained in closed systems that cannot extract nucleic acid extraction products for detection.

This kit uses magnetic beads with unique separation function and a unique buffer system to separate and purify high-quality virus from serum, plasma, lymph, cell-free body fluid, cell culture supernatant, urine or various virus preservation solutions DNA/RNA. The uniquely embedded magnetic beads have a strong affinity for nucleic acids under certain conditions, and when the conditions change, the magnetic beads release the adsorbed nucleic acids, which can achieve the purpose of rapid separation and purification of nucleic acids. The whole process is safe and convenient, and the extracted viral DNA/RNA has high yield, high purity, stable and reliable quality, and is especially suitable for automated extraction of high-throughput workstations. The nucleic acid purified by this kit can be applied to various routine operations, including RT-PCR, fluorescence quantitative PCR and other downstream experiments.

Nucleic Acid Lsolation Reagent Kits,Dna Purification Kit,Viral Rna Extraction Kits,Nucleic Acid Extraction Reagents

Jilin Sinoscience Technology Co. LTD , https://www.jilinsinoscience.com